Sentynl Therapeutics, Inc.

This program provides copper histidinate injections under the skin for children under 6 with Menkes disease, a rare genetic condition that prevents the body from using copper properly. The treatment aims to supply the copper the body needs to slow disease progression. It is avail…

This study gathers long-term health information from up to 50 people with Menkes disease, a rare genetic disorder. The goal is to track survival and nervous system changes over time. No new treatment is given; instead, researchers collect existing data to better understand the di…